packageCanakinumab

canakinumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Canakinumab is a monoclonal antibody that blocks interleukin signalling and is used to treat Cryopyrin-Associated Periodic Syndromes and juvenile idiopathic arthritis, with investigational use in gouty arthritis and cardiovascular conditions such as acute coronary syndrome. It is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q3655009 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:canakinumab
ATC codes:L04AC08
DrugBank:DB06168
Wikidata:Q3655009
molar mass:145157 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown